Zjablovskaja P, Danek P, Kardosova M, Alberich-Jorda M
J Vis Exp. 2018; (132).
PMID: 29553501
PMC: 5931329.
DOI: 10.3791/57033.
Breindel J, Haskins J, Cowell E, Zhao M, Nguyen D, Stern D
Cancer Res. 2013; 73(16):5053-65.
PMID: 23794705
PMC: 3745527.
DOI: 10.1158/0008-5472.CAN-12-3775.
Porter H, Carey G, Keegan A
Exp Cell Res. 2012; 318(14):1745-58.
PMID: 22652453
PMC: 3395425.
DOI: 10.1016/j.yexcr.2012.04.020.
Bonine-Summers A, Aakre M, Brown K, Arteaga C, Pietenpol J, Moses H
Cancer Biol Ther. 2007; 6(4):561-70.
PMID: 17495520
PMC: 3395216.
DOI: 10.4161/cbt.6.4.3851.
Lee J, Vivanco I, Beroukhim R, Huang J, Feng W, DeBiasi R
PLoS Med. 2006; 3(12):e485.
PMID: 17177598
PMC: 1702556.
DOI: 10.1371/journal.pmed.0030485.
Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth.
Maatta J, Sundvall M, Junttila T, Peri L, Laine V, Isola J
Mol Biol Cell. 2005; 17(1):67-79.
PMID: 16251361
PMC: 1345647.
DOI: 10.1091/mbc.e05-05-0402.
The tetraspanin CD9 associates with transmembrane TGF-alpha and regulates TGF-alpha-induced EGF receptor activation and cell proliferation.
Shi W, Fan H, Shum L, Derynck R
J Cell Biol. 2000; 148(3):591-602.
PMID: 10662783
PMC: 2174814.
DOI: 10.1083/jcb.148.3.591.
Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor.
Huang Y, Hwang J, Lee P, Ke F, Huang J, Huang C
Br J Pharmacol. 1999; 128(5):999-1010.
PMID: 10556937
PMC: 1571723.
DOI: 10.1038/sj.bjp.0702879.
Differential roles of Akt, Rac, and Ral in R-Ras-mediated cellular transformation, adhesion, and survival.
Osada M, Tolkacheva T, Li W, Chan T, Tsichlis P, Saez R
Mol Cell Biol. 1999; 19(9):6333-44.
PMID: 10454580
PMC: 84604.
DOI: 10.1128/MCB.19.9.6333.
A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor.
Izumi Y, Hirata M, Hasuwa H, Iwamoto R, Umata T, Miyado K
EMBO J. 1998; 17(24):7260-72.
PMID: 9857183
PMC: 1171072.
DOI: 10.1093/emboj/17.24.7260.
ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network.
Pinkas-Kramarski R, Shelly M, Guarino B, Wang L, Lyass L, Alroy I
Mol Cell Biol. 1998; 18(10):6090-101.
PMID: 9742126
PMC: 109195.
DOI: 10.1128/MCB.18.10.6090.
ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4.
Wang L, Kuo A, Alimandi M, Veri M, Lee C, Kapoor V
Proc Natl Acad Sci U S A. 1998; 95(12):6809-14.
PMID: 9618494
PMC: 22644.
DOI: 10.1073/pnas.95.12.6809.
Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
Alimandi M, Wang L, Bottaro D, Lee C, Kuo A, Frankel M
EMBO J. 1997; 16(18):5608-17.
PMID: 9312020
PMC: 1170193.
DOI: 10.1093/emboj/16.18.5608.
Regulation of Bcl-xL expression in human keratinocytes by cell-substratum adhesion and the epidermal growth factor receptor.
Rodeck U, Jost M, Duhadaway J, Kari C, Jensen P, Risse B
Proc Natl Acad Sci U S A. 1997; 94(10):5067-72.
PMID: 9144191
PMC: 24632.
DOI: 10.1073/pnas.94.10.5067.
Inhibition of signaling from Type 1 receptor tyrosine kinases via intracellular expression of single-chain antibodies.
Beerli R, Wels W, Hynes N
Breast Cancer Res Treat. 1996; 38(1):11-7.
PMID: 8825118
DOI: 10.1007/BF01803779.
A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies.
Almind K, Inoue G, Pedersen O, Kahn C
J Clin Invest. 1996; 97(11):2569-75.
PMID: 8647950
PMC: 507343.
DOI: 10.1172/JCI118705.
E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation.
Sparkowski J, Mense M, Anders J, Schlegel R
J Virol. 1996; 70(4):2420-30.
PMID: 8642670
PMC: 190085.
DOI: 10.1128/JVI.70.4.2420-2430.1996.
The Drosophila insulin receptor activates multiple signaling pathways but requires insulin receptor substrate proteins for DNA synthesis.
Yenush L, Fernandez R, Myers Jr M, Grammer T, Sun X, Blenis J
Mol Cell Biol. 1996; 16(5):2509-17.
PMID: 8628319
PMC: 231240.
DOI: 10.1128/MCB.16.5.2509.
Eps8, a substrate for the epidermal growth factor receptor kinase, enhances EGF-dependent mitogenic signals.
Fazioli F, Minichiello L, Matoska V, Castagnino P, Miki T, Wong W
EMBO J. 1993; 12(10):3799-808.
PMID: 8404850
PMC: 413663.
DOI: 10.1002/j.1460-2075.1993.tb06058.x.
EGF receptor in neoplasia and metastasis.
Khazaie K, Schirrmacher V, Lichtner R
Cancer Metastasis Rev. 1993; 12(3-4):255-74.
PMID: 8281612
DOI: 10.1007/BF00665957.